Please login to the form below

Not currently logged in
Email:
Password:

Vernalis Therapeutics appoints president and COO

Sandford Sommer brings experience from AstraZeneca

UK-based Vernalis Therapeutics has appointed Sandford Sommer as its new president and chief operating officer.

Ian Garland, chief executive of Vernalis, said: “We are delighted to welcome Sandy to Vernalis at this exciting time as we build our US commercial operations.

“Sandy's depth of experience in sales and marketing, as well as in general management, make him ideally qualified to lead our US operations through this critical period of multiple product launches and rapid growth.”

Sommer joins the development stage pharmaceutical company from AstraZeneca, where he has spent the past 24 years in a series of increasingly senior roles.

Most recently, Sommer served as country president for AstraZeneca's operations in Colombia and prior to that was global vice president, CNS.

He has also served on the board of the UK Columbia Trade organisation since March 2014.

Sommer said: “I am excited to be joining Vernalis at such an important time.

“I am looking forward to the opportunity to contribute to the growth of the company's US business and to help rapidly advance the company's promising pipeline.”

3rd May 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics